Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3474717 | Italian Journal of Medicine | 2011 | 11 Pages |
Abstract
Despite improved treatment, TTP is still associated with significant mortality (10-20%), particularly when plasma exchange is initiated late. Relapse also occurs in a substantial proportion of patients (10-40%) although the frequency of this outcome may be reduced by rituximab therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Deborah Melis, Gianluca Michelis, Marcello Brignone, Marina Cavaliere, Rodolfo Tassara,